Occult HBV infection and HCC

Occult HBV infection and HCC

<p class="MsoNormal"><span style="font-size: 10pt; font-family: QuorumITCbyBT-Book">A number of risk factors appear to play a role in Hepatocellularcinoma (HCC), HBV infection being one of the most important. Chronic inflammation and cytokines are key...

Full description

Bibliographic Details
Main Author:	Isabelle Chemin
Format:	Article
Language:	Spanish
Published:	Universidad de Antioquia 2007-02-01
Series:	Iatreia
Online Access:	http://www.iatreia.udea.edu.co/index.php/iatreia/article/view/847

Similar Items

Viral integration drives multifocal HCC during the occult HBV infection
by: Xiao-Ping Chen, et al.
Published: (2019-06-01)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
by: Xiao-Ping Chen, et al.
Published: (2019-12-01)

Occult HBV infection
by: Mariangela Spinosa, et al.
Published: (2010-09-01)

OCCULT HBV-INFECTION (CLINICAL REPORT)
by: I. A. Gabdrakhmanov, et al.
Published: (2017-04-01)

Special Issue: “Updates on HBV Infection”
by: Isabelle Chemin, et al.
Published: (2022-03-01)

Animal models for HCV and HBV studies
by: Isabelle Chemin
Published: (2007-02-01)

Updates on Hepatitis B Virus (HBV) Infection 2.0
by: Isabelle Chemin, et al.
Published: (2023-11-01)

Prevalence of Occult and Mutant HBV Infection in Hospitalized Haematological Patients
by: Semenenko T.A., et al.
Published: (2016-02-01)

Occult HBV infection among Egyptian hepatocellular carcinoma patients
by: Mansor Tarek M, et al.
Published: (2011-03-01)

High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable
by: Chengwei Wang, et al.
Published: (2023-05-01)

HBV profile of the occult HBV infection in blood donors at Maharaj Nakorn Chiang Mai Hospital
by: Nipapan Leetrakool, et al.
Published: (2013-01-01)

HBV-Induced Immune Imbalance in the Development of HCC
by: Yongyan Chen, et al.
Published: (2019-08-01)

Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC
by: Jiao Meng, et al.
Published: (2024-03-01)

Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg
by: Silvia Meschi, et al.
Published: (2024-03-01)

The relation of polymorphisms in +874 region of IFN-Gama with occult HBV infection
by: Kazemi Arababadi M (PhD), et al.
Published: (2010-03-01)

Occult HBV Infection: A Faceless Enemy in Liver Cancer Development
by: Jaime Morales-Romero, et al.
Published: (2014-04-01)

Chemotherapy and occult reactivation of HBV in hemodialysis patients
by: María Victoria Martín Hidalgo-Barquero, et al.
Published: (2020-09-01)

Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection.
by: Li-Ping Hu, et al.
Published: (2015-01-01)

Endemic HBV among hospital in-patients in Bangladesh, including evidence of occult infection.
by: Chowdhury, FR, et al.
Published: (2021)

Prevalence of Occult HBV Infection in Dialysis Patients Referred to Sari Dialysis Center
by: Lotfollah Davood, et al.
Published: (2023-10-01)

Occult HBV Infection Reactivation in Non-Hodgkin’s Lymphoma: An Update on Prevalence and Management
by: Valerio Rosato, et al.
Published: (2015-01-01)

Occult Hbv Infection in Hbsag Negative and Anti-Hbc Positive Blood Donors.
by: A Shebanizadeh, et al.
Published: (2007-04-01)

Occult HBV infection in patients with autoimmune hepatitis: A virological and clinical study
by: Xin-xin Chen, et al.
Published: (2020-12-01)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
by: De Battista D, et al.
Published: (2021-11-01)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
by: Wenhui Wang, et al.
Published: (2022-06-01)

Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC
by: Wanting Shi, et al.
Published: (2023-11-01)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Yan Huang, et al.
Published: (2022-06-01)

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
by: Muhammad Sajid, et al.
Published: (2022-05-01)

Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy
by: Alessia Sticchi Damiani, et al.
Published: (2023-12-01)

Prevalence of occult HBV infection among blood donors in Huzhou City，Zhejiang Province
by: MO Yanping, et al.
Published: (2022-03-01)

Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma
by: Maria Guarino, et al.
Published: (2017-03-01)

Insights of HBV Pathogenesis and Emerging Clinical Therapies for HBV Induced HCC Patients for a Better Prognostic Outcome
by: Reshmi Chatterjee
Published: (2015-02-01)

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
by: Hu Z, et al.
Published: (2022-04-01)

HBV COVALENTLY CLOSED CIRCULAR DNA AS A MARKER OF PREVALENCE OF OCCULT HEPATITIS В IN PATIENTS WITH HBV, HDV AND HCV INFECTION IN UZBEKISTAN
by: A. V. Semenov, et al.
Published: (2016-10-01)

Global prevalence of occult HBV infection in children and adolescents: A systematic review and meta-analysis
by: Jiaying Wu, et al.
Published: (2024-01-01)

The relationship between polymorphisms in intron 8 of vitamin D receptor gene and occult HBV infection
by: Rezvani ME, et al.
Published: (2009-08-01)

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
by: Costantini Andrea, et al.
Published: (2011-11-01)

Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC.
by: Xin Bai, et al.
Published: (2018-02-01)

Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC
by: Zhifeng Zhao, et al.
Published: (2021-09-01)

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
by: Vicki Wing-Ki Hui, et al.
Published: (2020-12-01)